Systems Integration Engineer/Scientist 1 at Illumina

Cambridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

Degree in a Biological or Physical Science, Chemistry, Bioengineering or equivalent
Understanding of next generation sequencing systems and library preparation
Basic wet laboratory experience
Knowledge/experience in molecular biology
Detail-oriented, organised and highly motivated
Proficiency in standard computer skills and statistical packages
Ability to work both independently and collaboratively
Good communications skills and ability to document procedures and results
Fast learner with problem solving abilities
Desire to be part of a fast paced, multidisciplinary and dynamic environment
Programming experience highly desirable (Python, Perl, LabView, etc.)
Programming experience of automated liquid handling systems would be a significant advantage

Responsibilities

Operation of Next Generation Sequencing instruments including performing manual and automated library preparation and quantifications
Hands-on testing and integration of DNA sequencing systems - hardware, software, chemistry, and full end-to-end workflows
Program liquid handlers and develop automated workflow with performance at least comparable to manual process
Execute design verification and validation test plans, collect data and prepare reports
Experiment planning, execution, troubleshooting, data analysis and interpretation
Analysis of complex/large data sets
Effective presentation and communication of results to colleagues

Skills

Next Generation Sequencing

NGS

Library Preparation

DNA Sequencing

Automation

Data Analysis

Hardware Integration

Software Integration

Chemistry Integration

Genomic Sequencing

Systems Integration

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free